Kelyniam Global, Inc. (KLYG)
USD 0.22
(22.22%)
USD 0.22
(22.22%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -197.69 Thousand USD | -2704.13% |
| 2022 | 16.74 Thousand USD | -102.78% |
| 2021 | 274.49 Thousand USD | 155.57% |
| 2020 | 99.34 Thousand USD | 215.38% |
| 2019 | -76.99 Thousand USD | -1249.53% |
| 2018 | 7499.00 USD | -94.94% |
| 2017 | 147.95 Thousand USD | 630.98% |
| 2016 | 28.17 Thousand USD | 302.81% |
| 2015 | -7482.00 USD | -112.79% |
| 2014 | 78 Thousand USD | -34.53% |
| 2013 | 119.14 Thousand USD | 0.0% |
| 2007 | -157.38 Thousand USD | -284.48% |
| 2006 | -72.6 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 147 Thousand USD | 32.92% |
| 2024 Q2 | 50.8 Thousand USD | -65.44% |
| 2023 Q1 | -93.79 Thousand USD | -3824.27% |
| 2023 FY | - USD | -3187.23% |
| 2023 Q2 | -139.03 Thousand USD | -48.24% |
| 2023 Q3 | -109.52 Thousand USD | 21.23% |
| 2023 Q4 | 110.59 Thousand USD | 200.98% |
| 2022 Q4 | -2390.00 USD | -107.67% |
| 2022 Q2 | -47.66 Thousand USD | -502.87% |
| 2022 Q1 | 11.83 Thousand USD | -81.09% |
| 2022 FY | - USD | -102.78% |
| 2022 Q3 | 31.16 Thousand USD | 165.38% |
| 2021 FY | - USD | 155.57% |
| 2021 Q2 | 55.2 Thousand USD | 90.87% |
| 2021 Q3 | 107.2 Thousand USD | 94.2% |
| 2021 Q1 | 28.92 Thousand USD | 144.59% |
| 2021 Q4 | 62.56 Thousand USD | -41.64% |
| 2020 Q1 | 90.11 Thousand USD | -34.37% |
| 2020 Q4 | -64.85 Thousand USD | -215.81% |
| 2020 FY | - USD | 215.38% |
| 2020 Q3 | 56 Thousand USD | 209.67% |
| 2020 Q2 | 18.08 Thousand USD | -79.93% |
| 2019 Q2 | -168.87 Thousand USD | -4650.61% |
| 2019 FY | - USD | -1249.53% |
| 2019 Q4 | 137.31 Thousand USD | 379.4% |
| 2019 Q1 | 3711.00 USD | 0.0% |
| 2019 Q3 | -49.14 Thousand USD | 70.9% |
| 2018 FY | - USD | -94.94% |
| 2017 FY | - USD | 630.98% |
| 2016 FY | - USD | 302.81% |
| 2015 FY | - USD | -112.79% |
| 2014 Q1 | 4.00 USD | 0.0% |
| 2014 FY | - USD | -34.53% |
| 2014 Q3 | 2.00 USD | 0.0% |
| 2014 Q4 | 1.00 USD | -50.0% |
| 2013 Q2 | -687.00 USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2008 Q1 | -54.03 Thousand USD | 63.49% |
| 2007 Q1 | 9144.00 USD | 0.0% |
| 2007 Q4 | -147.97 Thousand USD | -3401.59% |
| 2007 Q3 | -4226.00 USD | -5.31% |
| 2007 FY | - USD | -284.48% |
| 2007 Q2 | -4013.00 USD | -143.89% |
| 2006 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 27.926% |
| IR-Med Inc. | -4.89 Million USD | 95.959% |
| Polarean Imaging plc | -11.19 Million USD | 98.234% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 143.348% |
| Avitar, Inc. | -1.66 Million USD | 88.147% |
| AVITA Medical, Inc. | -39.56 Million USD | 99.5% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 83.016% |
| Össur hf. | 137.38 Million USD | 100.144% |
| Zecotek Photonics Inc. | -3.44 Million USD | 94.257% |
| QHSLab, Inc. | -91.29 Thousand USD | -116.546% |
| Wellstar International, Inc. | -1.35 Million USD | 85.427% |
| Össur hf. | 137.38 Million USD | 100.144% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 102.023% |
| Escalon Medical Corp. | -58.46 Thousand USD | -238.159% |
| Aurora Spine Corporation | -454.37 Thousand USD | 56.492% |
| BrainsWay Ltd. | -2.31 Million USD | 91.446% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 97.892% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 103.58% |
| Vivos Inc. | -2.79 Million USD | 92.922% |
| MicroPort Scientific Corporation | -347.57 Million USD | 99.943% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 88.152% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 47.826% |
| Nanomix Corporation | -8.13 Million USD | 97.571% |
| Theraclion SA | -2.05 Million USD | 90.36% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 72.039% |
| Positron Corporation | -1.45 Million USD | 86.386% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 88.519% |
| Lombard Medical, Inc. | -28.06 Million USD | 99.296% |
| ALR Technologies Inc. | -6.4 Million USD | 96.911% |
| Stratec SE | 39.91 Million USD | 100.495% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 295.844% |
| Heart Tronics, Inc. | -14.85 Million USD | 98.669% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -67.168% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 98.511% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 97.84% |
| VMS Rehab Systems, Inc. | -68.55 USD | -288289.497% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 93.676% |
| Ingen Technologies, Inc. | -8639.00 USD | -2188.355% |
| Odyssey Group International, Inc. | -2.13 Million USD | 90.754% |
| United American Healthcare Corporation | -59 Thousand USD | -235.069% |
| ECGI Holdings, Inc. | -2.99 Million USD | 93.389% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 68.58% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 61.541% |
| Urologix, Inc. | -6.34 Million USD | 96.884% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 84.049% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 74.191% |
| SS Innovations International, Inc. | -20.37 Million USD | 99.03% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 11.277% |
| Smith & Nephew plc | 1 Billion USD | 100.02% |
| NIOX Group Plc | 11.07 Million USD | 101.785% |
| Fuse Medical, Inc. | 1.83 Million USD | 110.771% |
| Broncus Holding Corporation | -25.19 Million USD | 99.215% |
| Brain Scientific Inc. | -7.93 Million USD | 97.508% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 97.895% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -974.408% |